CFTR and cystic fibrosis: While MRI has been shown to be a suitable tool for measuring responses to CFTR modulators and has the benefit of no exposure to radiation, the practical challenges and limited access, coupled with the low sensitivity of chest radiographs, means that CT will maintain its central position in CF thoracic imaging for the foreseeable future.